Safety and Efficacy of Linagliptin in Type-2-diabetes Mellitus Patients With Moderate to Severe Renal Impairment

1218.64.10007 Boehringer Ingelheim Investigational Site, Chula Vista

1218.64.10018 Boehringer Ingelheim Investigational Site, Pembroke Pines

1218.64.10016 Boehringer Ingelheim Investigational Site, Decatur

1218.64.10015 Boehringer Ingelheim Investigational Site, Boise

1218.64.10002 Boehringer Ingelheim Investigational Site, Chicago

1218.64.10004 Boehringer Ingelheim Investigational Site, Flint

1218.64.10006 Boehringer Ingelheim Investigational Site, Kansas City

1218.64.10003 Boehringer Ingelheim Investigational Site, The Bronx

1218.64.10013 Boehringer Ingelheim Investigational Site, Philadelphia

1218.64.10020 Boehringer Ingelheim Investigational Site, Philadelphia

1218.64.10008 Boehringer Ingelheim Investigational Site, Pittsburgh

1218.64.10009 Boehringer Ingelheim Investigational Site, Arlington

1218.64.10005 Boehringer Ingelheim Investigational Site, Dallas

1218.64.10011 Boehringer Ingelheim Investigational Site, Houston

1218.64.10014 Boehringer Ingelheim Investigational Site, Houston

1218.64.10010 Boehringer Ingelheim Investigational Site, Tacoma

1218.64.61005 Boehringer Ingelheim Investigational Site, Gosford

1218.64.61001 Boehringer Ingelheim Investigational Site, Liverpool

1218.64.61002 Boehringer Ingelheim Investigational Site, St Leonards

1218.64.61003 Boehringer Ingelheim Investigational Site, Adelaide

1218.64.61004 Boehringer Ingelheim Investigational Site, Reservoir

1218.64.20008 Boehringer Ingelheim Investigational Site, Corunna

1218.64.20005 Boehringer Ingelheim Investigational Site, Hamilton

1218.64.20007 Boehringer Ingelheim Investigational Site, Hamilton

1218.64.20002 Boehringer Ingelheim Investigational Site, Sarnia

1218.64.20009 Boehringer Ingelheim Investigational Site, Stayner

1218.64.20004 Boehringer Ingelheim Investigational Site, Toronto

1218.64.20003 Boehringer Ingelheim Investigational Site, Point Claire

1218.64.35804 Boehringer Ingelheim Investigational Site, Kokkola

1218.64.35803 Boehringer Ingelheim Investigational Site, Oulu

1218.64.35801 Boehringer Ingelheim Investigational Site, Turku

1218.64.97204 Boehringer Ingelheim Investigational Site, Ashkelon

1218.64.97207 Boehringer Ingelheim Investigational Site, Giv‘atayim

1218.64.97203 Boehringer Ingelheim Investigational Site, Haifa

1218.64.97201 Boehringer Ingelheim Investigational Site, Jerusalem

1218.64.97202 Boehringer Ingelheim Investigational Site, Nahariya

1218.64.97206 Boehringer Ingelheim Investigational Site, Tel Aviv

1218.64.81005 Boehringer Ingelheim Investigational Site, Asahi, Chiba

1218.64.81006 Boehringer Ingelheim Investigational Site, Isesaki, Gunma

1218.64.81001 Boehringer Ingelheim Investigational Site, Meguro-ku, Tokyo

1218.64.81008 Boehringer Ingelheim Investigational Site, Nagoya, Aichi

1218.64.81007 Boehringer Ingelheim Investigational Site, Osaka, Osaka

1218.64.81002 Boehringer Ingelheim Investigational Site, Shinjyuku-ku,Tokyo

1218.64.81004 Boehringer Ingelheim Investigational Site, Suita, Osaka

1218.64.81003 Boehringer Ingelheim Investigational Site, Suwa, Nagano

1218.64.64001 Boehringer Ingelheim Investigational Site, Otahuhu Auckland

1218.64.42102 Boehringer Ingelheim Investigational Site, Bratislava

1218.64.42107 Boehringer Ingelheim Investigational Site, Košice

1218.64.42109 Boehringer Ingelheim Investigational Site, Nitra

1218.64.42108 Boehringer Ingelheim Investigational Site, Trenčín

1218.64.46002 Boehringer Ingelheim Investigational Site, Härnösand

1218.64.46003 Boehringer Ingelheim Investigational Site, Helsingborg